登录 | 注册    关注公众号  
微信公众号
搜索
 > 【CD30】

CD30信息

英文名称:Tumor necrosis factor receptor superfamily member 8
中文名称:肿瘤坏死因子受体超家族成员8
靶点别称:CD30,CD30L receptor,TNFRSF8,Lymphocyte activation antigen CD30,TNF Receptor Superfamily Member 8,D1S166E,Tumor Necrosis Factor Receptor Superfamily, Member 8,Cytokine Receptor CD30,CD30 Antigen,Ki-1,Ki-1 Antigen,Tumor Necrosis Factor Receptor Superfamily Member 8
上市药物数量:1
临床药物数量:21
最高研发阶段:批准上市

CD30分子别名

TNFRSF8,CD30,D1S166E,Ki-1

CD30分子背景

Human CD30 is also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker. TNFRSF-8 is expressed by activated, but not by resting, T and B cells. Also, CD30 is expressed on classical Hodgkin Lymphoma cells together with CD15. CD30 is the receptor for TNFSF8/CD30L. CD30 can interact with TRAF2 and TRAF5, and mediate the signal transduction that leads to the activation of NF-kappa-B. TNFRSF8 may play a role in the regulation of cellular growth and transformation of activated lymphoblasts. TNFRSF8 is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity.

CD30上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

CD30临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定